サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629899

バイオベースパッケージングの世界市場 - 2025年～2033年

Global Bio Based Packaging Market - 2025-2033

出版日
ページ情報
英文 159 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
バイオベースパッケージングの世界市場 - 2025年～2033年
出版日: 2024年12月30日
発行: DataM Intelligence
ページ情報: 英文 159 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のバイオベースパッケージング市場は、2024年に19億米ドルに達し、2033年には40億米ドルに達すると予測され、予測期間2025年～2033年のCAGRは8.5%で成長するとされています。

ヘルスケアバイオベースパッケージングとは、医薬品、医療機器、ヘルスケア業界向けに特別に設計されたパッケージングソリューションのことで、従来のプラスチックやその他の非生分解性材料ではなく、再生可能な生物由来の材料から作られています。これらのパッケージングソリューションは、無菌性、バリア保護、耐久性、安全性といったヘルスケア分野の厳しい要件を満たすと同時に、環境にも配慮して開発されています。

ヘルスケア企業や消費者が持続可能性の重要性を認識し、包装材料が環境に与える影響を軽減するにつれて、ヘルスケア分野におけるバイオベースパッケージングの需要は着実に伸びています。例えば、英国製薬工業協会（ABPI）によると、カーボンフットプリントの約70～80％は製造工程にあり、その製造工程の設計者や発明者が言うように、決定はその医薬品の有用期間中ずっと影響します。

市場力学：

促進要因と抑制要因

製薬企業の持続可能性目標の高まり

製薬企業の持続可能性目標の高まりは、バイオベースパッケージング市場の成長を大きく後押ししており、予測期間中も市場を牽引すると予想されます。大手製薬企業は、バイオベースパッケージング材を使用して持続可能性を企業戦略に組み込むことで、ネットゼロエミッションの達成やカーボンフットプリントの削減など、野心的な持続可能性目標を設定し、これらの目標を達成しようとしています。

例えば、2024年10月、TekniPlexヘルスケアは、初のISCC PLUS認定バイオベースPVCコンパウンドを発表し、医療用包装に持続可能な代替品を提供しました。同社の新材料は、チューブ、トレイ用フィルム、パウチ、その他のプラスチック部品などの医療包装用途に使用されるよう設計されており、環境に優しい選択肢を提供します。再生可能エネルギーで作られた同社のコンパウンドは、CO2排出量を最大90％削減し、ヘルスケア業界が性能や安全性を失うことなく、より持続可能なパッケージングを実現できるよう支援します。

FDAやEMAなどの規制機関は、ヘルスケア分野における包装資材の環境負荷低減にますます力を入れています。これらの規制は、ISOコンプライアンスなどの認証を取得することにより、バイオベースパッケージング材料の使用を含む持続可能な慣行の採用を奨励しています。

例えば、2024年1月、特殊で持続可能な材料ソリューションとサービスの大手プロバイダーであるAvient Corporationは、Pharmapack 2024でバイオベースポリマーソリューションのポートフォリオを紹介すると発表しました。これらのソリューションには、バイオベースポリマーの着色料や添加剤、バイオ由来の熱可塑性エラストマーが含まれ、ISO 14067準拠のためにTUV Rheinlandによって認証されたアビエントのPCF計算機によって立証された、より低い製品カーボンフットプリント（PCF）値が含まれます。

厳しい規制要件

厳しい規制要件は、コンプライアンスを複雑にし、コストを増加させ、市場導入を制限する障壁を作り出すことによって、バイオベースパッケージング市場の成長を著しく妨げています。これらの規制は、医薬品包装の重要な性質のため、ヘルスケア分野では特に厳しいです。バイオベースパッケージングは、医薬品用途における安全性、無菌性、機能性に関して、従来の材料と同様の厳格な基準を満たす必要があります。これには、厳格な生体適合性試験、安定性試験、包装内の薬剤や医療機器との適合性などが含まれます。

例えば、FDAは、バイオベースパッケージング材料が、医薬品や医療機器などの内容物と悪影響を及ぼさないことを実証するために、広範な試験を受けることを要求しています。同様に、材料が有害物質を溶出したり、医薬品や医療機器の完全性を損なったりしてはならないです。これらの要件により、従来のプラスチックと比較して、バイオベース材料の規制プロセスはより複雑で時間のかかるものとなっています。

バイオベースマテリアルに対する規制要件は地域によって大きく異なるため、製品を世界に販売しようとする企業にとっては課題が生じる。例えば、米国のFDAはEUのREACH（化学物質の登録・評価・認可・制限）規制とは異なる規制を設けています。こうした違いが、バイオベースのパッケージングメーカーが国際市場向けに製品を標準化する能力を複雑にしています。

目次

第1章 市場イントロダクションと範囲

  • 報告書の目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • 材料タイプ別
  • 用途別
  • 地域別

第3章 市場力学

  • 影響要因
    • 促進要因
      • 製薬会社の持続可能性目標の高まり
    • 抑制要因
      • 厳格な規制要件
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名な企業
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • 新興スタートアップ企業と主要イノベーター
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学

第5章 バイオベースパッケージング市場、材料タイプ別

  • 生分解性プラスチック
  • 生分解性紙と板紙
  • 生分解性フィルム
  • その他

第6章 バイオベースパッケージング市場、用途別

  • 製薬およびバイオ医薬品産業
  • 栄養補助食品会社
  • パーソナルケアと化粧品
  • その他

第7章 バイオベースパッケージング市場、地域別、市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第8章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要な市場企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第9章 企業プロファイル

  • Amcor plc
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • Gerresheimer AG
  • SCHOTT Pharma
  • Becton, Dickinson, and Company
  • DS Smith
  • Berry Global Inc.
  • Smurfit Kappa
  • Sanner GmbH
  • Avient Corporation
  • Bormioli Pharma S.p.A.

第10章 仮定と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証と検証

第11章 付録

目次
Product Code: OT8933

The global bio based packaging market reached US$ 1.9 billion in 2024 and is expected to reach US$ 4.0 billion by 2033, growing at a CAGR of 8.5% during the forecast period 2025-2033.

Healthcare bio-based packaging refers to packaging solutions specifically designed for the pharmaceutical, medical device, and healthcare industries that are made from renewable, biologically sourced materials rather than conventional plastics or other non-biodegradable materials. These packaging solutions are developed to meet the stringent requirements of the healthcare sector, such as sterility, barrier protection, durability, and safety, while also being environmentally friendly.

The demand for bio-based packaging in the healthcare sector has been growing steadily as healthcare companies and consumers alike recognize the importance of sustainability and reducing the environmental impact of packaging materials. For instance, according to the Association of the British Pharmaceutical Industry (ABPI), about 70 to 80% of the carbon footprint sits in the manufacturing process and as the designers and inventors of those manufacturing processes say the decisions made will live with that product for the rest of its useful life as a medicine.

Market Dynamics: Drivers & Restraints

Rising sustainability goals of pharmaceutical companies

The rising sustainability goals of pharmaceutical companies are significantly driving the growth of the bio based packaging market and are expected to drive the market over the forecast period. Major pharmaceutical companies are setting ambitious sustainability targets, such as achieving net-zero emissions or reducing their carbon footprint by integrating sustainability into their corporate strategies by using bio-based packaging materials to meet these goals.

For instance, in October 2024, TekniPlex Healthcare unveiled the first ISCC PLUS-certified bio-based PVC compounds, offering a sustainable alternative for medical packaging. Its new materials are designed for use in medical packaging applications like tubing, films for trays, pouches, and other plastic components, providing eco-friendly options. Made with renewable energy, its compounds reduce CO2 emissions by up to 90%, helping the healthcare industry create more sustainable packaging without losing performance or safety.

Regulatory bodies, such as the FDA and EMA, are increasingly focused on reducing the environmental impact of packaging materials in the healthcare sector. These regulations encourage the adoption of sustainable practices, including the use of bio-based packaging materials by obtaining certifications like ISO compliance.

For instance, in January 2024, Avient Corporation, a leading provider of specialized and sustainable material solutions and services, announced it is highlighting its portfolio of bio-based polymer solutions at Pharmapack 2024. These solutions include bio-based polymer colorants and additives and bio-derived thermoplastic elastomers with lower product carbon footprint (PCF) values substantiated by Avient's PCF Calculator certified by TUV Rheinland for ISO 14067 compliance.

Stringent regulatory requirements

Stringent regulatory requirements significantly hamper the growth of the bio-based packaging market by creating barriers that complicate compliance, increase costs and limit market adoption. These regulations are particularly stringent in the healthcare sector due to the critical nature of pharmaceutical packaging. Bio-based packaging must meet the same rigorous standards as traditional materials for safety, sterility, and functionality in pharmaceutical applications. This includes rigorous biocompatibility tests, stability tests, and compatibility with the drug or medical device within the packaging.

For instance, the FDA requires bio-based packaging materials to undergo extensive testing to demonstrate that they do not interact negatively with the contents, such as pharmaceuticals or medical devices. Like, materials must not leach harmful substances or compromise the integrity of the drug or device. These requirements make the regulatory process more complex and time-consuming for bio-based materials compared to traditional plastics.

The regulatory requirements for bio-based materials vary significantly across different regions, creating challenges for companies looking to market their products globally. For instance, the FDA in the U.S. has different regulations compared to the EU's REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) regulations. These differences complicate the ability of bio-based packaging manufacturers to standardize their products for international markets.

Segment Analysis

The global bio based packaging market is segmented based on material type, application and region.

Material Type:

The biodegradable plastics segment is expected to dominate the bio based packaging market share

Biodegradable plastics are derived from renewable resources like corn starch, sugarcane, or polylactic acid (PLA). These materials can break down more easily in natural environments, reducing the overall environmental footprint compared to conventional plastics, which can persist for hundreds of years in landfills. Biodegradable plastics can be engineered to have similar properties to traditional plastics, such as durability, moisture resistance, and chemical resistance, making them suitable for packaging pharmaceuticals and medical devices.

For instance, in October 2024, Bayer launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve. Realized in partnership with pharma packaging specialist Liveo Research, this innovative solution reduces the carbon footprint of this packaging by 38% and marks a stride in environmental stewardship by eliminating the use of polyvinyl chloride (PVC).

Rising investments in biodegradable plastics are also increasing the market demand. For instance, in September 2024, Darmstadt-based BIOVOX announced the successful closing of its €2.2 million seed round. The round was led by High-Tech Grunderfonds (HTGF) with significant participation from Beteiligungs-Managementgesellschaft Hessen mbH (BMH) and a group of existing and new investors including Auxxo, Otto Braun, Petra Worwag and Katharina Klohe as well members of the business angel club better ventures and Business Angels FrankfurtRheinMain. The investment will enable BIOVOX to accelerate the development and production of its portfolio of innovative bioplastic solutions designed to revolutionize the healthcare industry.

Geographical Analysis

North America is expected to hold a significant position in the bio based packaging market share

North America, particularly the United States and Canada, has a strong regulatory framework that encourages the adoption of sustainable packaging materials in the healthcare sector. The US FDA and Canadian regulatory bodies are pushing for more sustainable solutions to reduce the environmental impact of pharmaceutical packaging.

For instance, the FDA has issued guidance on the use of environmentally friendly packaging materials, including bio-based plastics, to ensure the safety and efficacy of pharmaceuticals. The directive is aimed at promoting packaging that is not only effective in protecting products but also sustainable.

In North America, there is a growing consumer preference for environmentally friendly products, which influences pharmaceutical companies to seek sustainable packaging solutions. Consumers are becoming more aware of the environmental impact of packaging materials and are demanding more eco-friendly options. This trend is particularly strong among younger demographics, who are more likely to choose sustainable products. For instance, according to the survey conducted by Accenture found that 83% of US consumers believe it's important for companies to design products that are environmentally friendly.

Asia-Pacific is growing at the fastest pace in the bio based packaging market

The Asia-Pacific region is witnessing significant economic growth, especially in countries like China, India, and Japan. This economic development is leading to an increased demand for healthcare products, which in turn drives the need for sustainable packaging solutions. As disposable incomes rise and urbanization accelerates, consumers are becoming more aware of the environmental impact of packaging and are increasingly demanding eco-friendly alternatives.

For instance, in China, the healthcare packaging market is expanding rapidly due to an aging population and increased healthcare spending. This growth is prompting the adoption of bio-based packaging to meet the demands of the pharmaceutical industry, which is under pressure to reduce waste and comply with stricter environmental regulations.

Major pharmaceutical companies in the APAC region are setting ambitious sustainability targets and are actively seeking bio-based packaging solutions to meet these goals. For example, companies like Cipla, Sun Pharmaceutical Industries, and Aurobindo Pharma in India are increasingly using bio-based packaging materials to meet global standards and enhance their sustainability profiles.

Competitive Landscape

The major global players in the bio based packaging market include Amcor plc, Gerresheimer AG, SCHOTT Pharma, Becton, Dickinson, and Company, DS Smith, Berry Global Inc., Smurfit Kappa, Sanner GmbH, Avient Corporation, Bormioli Pharma S.p.A. and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global bio based packaging market report delivers a detailed analysis with 54 key tables, more than 44 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Material Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising sustainability goals of pharmaceutical companies
    • 3.1.2. Restraints
      • 3.1.2.1. Stringent regulatory requirements
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Bio Based Packaging Market, By Material Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 5.1.2. Market Attractiveness Index, By Material Type
  • 5.2. Biodegradable Plastics*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Biodegradable Paper and Paperboard
  • 5.4. Biodegradable Films
  • 5.5. Others

6. Bio Based Packaging Market, By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Pharmaceutical & Biopharmaceutical Industries*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Nutraceutical Companies
  • 6.4. Personal Care and Cosmetics
  • 6.5. Others

7. Bio Based Packaging Market, By Regional Market Analysis and Growth Opportunities

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 7.1.2. Market Attractiveness Index, By Region
  • 7.2. North America
    • 7.2.1. Introduction
    • 7.2.2. Key Region-Specific Dynamics
    • 7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.2.5.1. U.S.
      • 7.2.5.2. Canada
      • 7.2.5.3. Mexico
  • 7.3. Europe
    • 7.3.1. Introduction
    • 7.3.2. Key Region-Specific Dynamics
    • 7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.3.5.1. Germany
      • 7.3.5.2. U.K.
      • 7.3.5.3. France
      • 7.3.5.4. Spain
      • 7.3.5.5. Italy
      • 7.3.5.6. Rest of Europe
  • 7.4. South America
    • 7.4.1. Introduction
    • 7.4.2. Key Region-Specific Dynamics
    • 7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.4.5.1. Brazil
      • 7.4.5.2. Argentina
      • 7.4.5.3. Rest of South America
  • 7.5. Asia-Pacific
    • 7.5.1. Introduction
    • 7.5.2. Key Region-Specific Dynamics
    • 7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.5.5.1. China
      • 7.5.5.2. India
      • 7.5.5.3. Japan
      • 7.5.5.4. South Korea
      • 7.5.5.5. Rest of Asia-Pacific
  • 7.6. Middle East and Africa
    • 7.6.1. Introduction
    • 7.6.2. Key Region-Specific Dynamics
    • 7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

8. Competitive Landscape and Market Positioning

  • 8.1. Competitive Overview and Key Market Players
  • 8.2. Market Share Analysis and Positioning Matrix
  • 8.3. Strategic Partnerships, Mergers & Acquisitions
  • 8.4. Key Developments in Product Portfolios and Innovations
  • 8.5. Company Benchmarking

9. Company Profiles

  • 9.1. Amcor plc*
    • 9.1.1. Company Overview
    • 9.1.2. Product Portfolio and Description
    • 9.1.3. Financial Overview
    • 9.1.4. Key Developments
    • 9.1.5. SWOT Analysis
  • 9.2. Gerresheimer AG
  • 9.3. SCHOTT Pharma
  • 9.4. Becton, Dickinson, and Company
  • 9.5. DS Smith
  • 9.6. Berry Global Inc.
  • 9.7. Smurfit Kappa
  • 9.8. Sanner GmbH
  • 9.9. Avient Corporation
  • 9.10. Bormioli Pharma S.p.A.

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

  • 10.1. Data Collection Methods
  • 10.2. Data Triangulation
  • 10.3. Forecasting Techniques
  • 10.4. Data Verification and Validation

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us